ArticleJournal of personalized medicine2021

Evaluation of Drug-Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors.

Mario Occhipinti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.